Geodon (Ziprasidone) is an atypical antipsychotic medication that has been approved by the FDA since 2001 to treat schizophrenia. It has also been found effective in addressing manic symptoms among individuals with bipolar disorder. In other cases, it is even used on an off-label basis as an antidepressant augmentation strategy and for various types of …
One of the most frustrating experiences for any student going to school or working adult is experiencing “brain fog.” When brain fog hits, it’s almost as if our previously efficient brain has filled up with clouds or “fog” that prevents us from thinking clearly. Brain fog is typically characterized as an inability to focus, poor …
Seroquel (Quetiapine) is an atypical antipsychotic drug that is used primarily for the treatment of schizophrenia and in some cases, bipolar disorder. It is also a relatively popular antidepressant augmentation strategy for individuals who don’t respond to monotherapeutic options. Off-label some doctors prescribe it at low doses for Tourette syndrome, insomnia and anxiety disorders, despite …
Risperdal (Risperidone) is an atypical antipsychotic drug that is primarily utilized to manage symptoms of schizophrenia. Additionally the drug is commonly prescribed for other conditions such as schizoaffective disorder, bipolar disorder, and for irritability associated with autism. It was initially approved by the FDA in 1994 and at the time was considered to be an …
Haldol (Haloperidol) is a medication that is most commonly used to treat schizophrenia. In some cases it is also used to help manage acute psychosis, mania in bipolar disorder, and tics in Tourette syndrome. It is considered a first-generation “typical” antipsychotic drug and was initially approved by the FDA in 1967. Haldol is a regarded …
Fetzima (Levomilnacipran) is a serotonin-norepinephrine reuptake inhibitor that was approved by the FDA in 2013 to treat major depression. It is similar to the older drug milnacipran, but contains the “levo”-stereoisomer – making it slightly different. This antidepressant is regarded as being significantly different from other SNRIs in that it inhibits norepinephrine reuptake to a greater …
Brintellix (Vortioxetine) is a drug that was approved by the FDA in 2013 to treat major depression. It is regarded as an atypical antidepressant, meaning that it’s mechanisms of action are unique from other classifications. As the marketing and promotion of this newer (2013) antidepressant continues, the number of people experimenting with it for their …